• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚妊娠期间接受抗逆转录病毒治疗的 HIV 感染妇女不良妊娠结局的预测因素。

Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy.

机构信息

University of Washington, Seattle, Washington, USA.

Kenyatta National Hospital, Nairobi, Kenya.

出版信息

AIDS. 2022 Jun 1;36(7):1007-1019. doi: 10.1097/QAD.0000000000003215. Epub 2022 Mar 4.

DOI:10.1097/QAD.0000000000003215
PMID:35652673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9178912/
Abstract

OBJECTIVE

The aim of this study was to understand predictors of adverse pregnancy outcomes (APOs) among women on antiretroviral treatment (ART).

DESIGN

A longitudinal cohort.

METHODS

Participants from the Mobile WAChX trial were evaluated for APOs, including stillbirth (fetal death at ≥20 weeks' gestation), preterm birth (PTB, livebirth at <37 weeks' gestation,) and neonatal death (NND, ≤28 days after live birth). Predictors were determined by univariable and multivariable Cox proportional hazards and log-binomial models.

RESULTS

Among 774 women included, median age was 27 years and 29.0% had unsuppressed HIV viral load (>1000 copies/ml) at enrollment. Half (55.1%) started ART prepregnancy, 89.1% on tenofovir-based regimens. Women with depression had a higher risk of stillbirth (adjusted hazard ratio [aHR] 2.93, 95% confidence interval (95% CI) 1.04-8.23), and women with lower social support score had higher risk of late stillbirth (aHR 11.74, 2.47-55.86). Among 740 livebirths, 201 (27.2%) were preterm and 22 (3.0%) experienced NND. PTB was associated with unsuppressed maternal viral load (adjusted prevalence ratio [aPR] 1.28, 95% CI 1.02-1.61), intimate partner violence (IPV) in pregnancy (aPR 1.94, 95% CI 1.28-2.94), and history of any sexually transmitted infection (STI) (aPR 1.63, 95% CI 1.06-2.51). NND was associated with PTB (aPR 2.53, 95% CI 1.10-5.78) and STI history (aPR 4.25, 95% CI 1.39-13.06). Most associations retained significance in the subgroup of women with viral suppression.

CONCLUSION

Maternal viremia during pregnancy predicted PTB as did IPV, lower education, and STI history, while psychosocial stressors predicted stillbirth. Implementing mental health services, ART adherence, partner support, and routine STI screening and treatment could reduce APOs among women with HIV in sub-Saharan Africa settings.

摘要

目的

本研究旨在了解接受抗逆转录病毒治疗(ART)的女性不良妊娠结局(APO)的预测因素。

设计

纵向队列研究。

方法

对 Mobile WAChX 试验中的参与者进行 APO 评估,包括死胎(妊娠 20 周及以上的胎儿死亡)、早产(PTB,妊娠 37 周及以下的活产)和新生儿死亡(NND,活产后 28 天内死亡)。通过单变量和多变量 Cox 比例风险和对数二项式模型确定预测因素。

结果

在纳入的 774 名女性中,中位年龄为 27 岁,29.0%在入组时 HIV 病毒载量未得到抑制(>1000 拷贝/ml)。一半(55.1%)在妊娠前开始接受 ART,89.1%使用基于替诺福韦的方案。患有抑郁症的女性死胎风险更高(调整后的危险比 [aHR] 2.93,95%置信区间 [95%CI] 1.04-8.23),社会支持评分较低的女性晚死胎风险更高(aHR 11.74,95%CI 2.47-55.86)。在 740 例活产中,201 例(27.2%)早产,22 例(3.0%)新生儿死亡。未抑制的母体病毒载量(调整后的患病率比[aPR] 1.28,95%CI 1.02-1.61)、妊娠期间的亲密伴侣暴力(IPV)(aPR 1.94,95%CI 1.28-2.94)和既往性传播感染(STI)史(aPR 1.63,95%CI 1.06-2.51)与 PTB 相关。NND 与 PTB 相关(aPR 2.53,95%CI 1.10-5.78)和 STI 史(aPR 4.25,95%CI 1.39-13.06)相关。大多数关联在病毒抑制的女性亚组中仍然具有统计学意义。

结论

妊娠期间的母体病毒血症预测 PTB,IPV、较低的教育程度和 STI 史也有预测作用,而心理社会压力因素预测死胎。在撒哈拉以南非洲地区,实施心理健康服务、ART 依从性、伴侣支持以及常规性传播感染筛查和治疗,可能会降低 HIV 女性的 APO。

相似文献

1
Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy.肯尼亚妊娠期间接受抗逆转录病毒治疗的 HIV 感染妇女不良妊娠结局的预测因素。
AIDS. 2022 Jun 1;36(7):1007-1019. doi: 10.1097/QAD.0000000000003215. Epub 2022 Mar 4.
2
Maternal HIV infection and risk of adverse pregnancy outcomes in Hunan province, China: A prospective cohort study.中国湖南省孕产妇感染艾滋病毒与不良妊娠结局风险:一项前瞻性队列研究
Medicine (Baltimore). 2020 Feb;99(8):e19213. doi: 10.1097/MD.0000000000019213.
3
Risks of adverse perinatal outcomes in relation to maternal depressive symptoms: A prospective cohort study in Kenya.与产妇抑郁症状相关的不良围产结局风险:肯尼亚的一项前瞻性队列研究。
Paediatr Perinat Epidemiol. 2023 Aug;37(6):489-504. doi: 10.1111/ppe.12978. Epub 2023 Apr 26.
4
Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana.在博茨瓦纳的一项出生监测研究中,从受孕开始接受抗逆转录病毒治疗的女性的体重与出生结局。
J Int AIDS Soc. 2021 Jun;24(6):e25763. doi: 10.1002/jia2.25763.
5
Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study.博茨瓦纳开展的一项观察性研究:在孕期开始使用多替拉韦或依非韦伦为基础的抗逆转录病毒治疗的安全性比较。
Lancet Glob Health. 2018 Jul;6(7):e804-e810. doi: 10.1016/S2214-109X(18)30218-3. Epub 2018 Jun 4.
6
Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa.南非妊娠期间母婴 HIV 和抗逆转录病毒治疗与准确的孕龄相关的围产期结局。
AIDS. 2019 Aug 1;33(10):1623-1633. doi: 10.1097/QAD.0000000000002222.
7
Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis.与 HIV 感染孕妇中使用基于蛋白酶抑制剂与非核苷类逆转录酶抑制剂的抗逆转录病毒联合治疗方案相关的不良围生期结局:系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2023 Jan 30;23(1):80. doi: 10.1186/s12884-023-05347-5.
8
Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.孕期抗逆转录病毒治疗方案的比较安全性
JAMA Pediatr. 2017 Oct 2;171(10):e172222. doi: 10.1001/jamapediatrics.2017.2222.
9
Associations between HIV, antiretroviral therapy and preterm birth in the US Women's Interagency HIV Study, 1995-2018: a prospective cohort.1995-2018 年美国妇女艾滋病研究机构 HIV、抗逆转录病毒疗法与早产的相关性:一项前瞻性队列研究。
HIV Med. 2022 Apr;23(4):406-416. doi: 10.1111/hiv.13171. Epub 2021 Sep 12.
10
Chlamydia, Gonorrhea, and Incident HIV Infection During Pregnancy Predict Preterm Birth Despite Treatment.沙眼衣原体、淋病和妊娠期间新发 HIV 感染可预测早产,即使经治疗亦如此。
J Infect Dis. 2021 Dec 15;224(12):2085-2093. doi: 10.1093/infdis/jiab277.

引用本文的文献

1
Factors associated with preterm birth and mother-to-child transmission in HIV-positive pregnant women in Henan, China, 2016-2022: a retrospective cohort study.2016 - 2022年中国河南HIV阳性孕妇早产及母婴传播相关因素:一项回顾性队列研究
BMJ Open. 2024 Dec 15;14(12):e082805. doi: 10.1136/bmjopen-2023-082805.
2
Fetal, neonatal, and infant death among offspring of pregnant women with HIV in Tanzania.坦桑尼亚孕妇艾滋病毒感染对其后代的胎儿、新生儿和婴儿死亡的影响。
AIDS. 2024 Nov 15;38(14):1947-1955. doi: 10.1097/QAD.0000000000003985. Epub 2024 Jul 30.
3
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential.具有生殖潜能的女性使用抗逆转录病毒药物面临的挑战、风险和机遇。
Expert Rev Anti Infect Ther. 2024 Apr;22(4):153-167. doi: 10.1080/14787210.2024.2334054. Epub 2024 Mar 27.
4
Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?目前推荐的预防乙型肝炎病毒母婴传播的母体抗病毒预防措施是否需要加强?
JHEP Rep. 2023 Jun 29;5(11):100831. doi: 10.1016/j.jhepr.2023.100831. eCollection 2023 Nov.
5
Adverse pregnancy outcomes associated with antiretroviral therapy initiated before pregnancy and during pregnancy: a retrospective study in Hubei province, China.孕前及孕期开始抗逆转录病毒治疗相关的不良妊娠结局:中国湖北省的一项回顾性研究
Front Med (Lausanne). 2023 May 18;10:1158962. doi: 10.3389/fmed.2023.1158962. eCollection 2023.